EXAMPLE: NZ Neurology Research Review Issue 92 – MS Focus

In this issue:
– Ethnic and socioeconomic disparities in DMT use in NZ
– Clinic follow-up visits do not affect mortality in pwMS
– Finite-course vs standard interval dosing of ocrelizumab in relapsing MS
– Impact of NMOSD on employment rates
– Impact of different DMT reimbursement policies in Slovenia and Croatia
– PIRA in the era of high efficacy treatments
– Types of pain in pwMS
– Disease course from onset of MS to secondary progression
– aHSCT affects long-term PIRA in patients with aggressive MS
– MS fatigue post high-efficacy treatment